메뉴 건너뛰기




Volumn 111, Issue 16, 2005, Pages 2107-2111

Effectiveness and safety of sirolimus-eluting stents in the treatment of restenosis after coronary stent placement

(12)  Neumann, Franz Josef a   Desmet, Walter b   Grube, Eberhard c   Brachmann, Johannes d   Presbitero, Patrizia e   Rubartelli, Paolo f   Mügge, Andreas g   Di Pede, Francesco h   Füllgraf, Diana i   Aengevaeren, Wim j   Spedicato, Leonardo k   Popma, Jeffrey J l  


Author keywords

Restenosis; Sirolimus; Stents

Indexed keywords

RAPAMYCIN;

EID: 20244388656     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000162467.53001.6B     Document Type: Article
Times cited : (96)

References (33)
  • 8
    • 0032867681 scopus 로고    scopus 로고
    • Clinical and angiographic follow-up after balloon angioplasty with provisional stenting for coronary in-stent restenosis
    • Elezi S, Kastrati A, Hadamitzky M, Dirschinger J, Neumann FJ, Schömig A. Clinical and angiographic follow-up after balloon angioplasty with provisional stenting for coronary in-stent restenosis. Catheter Cardiovasc Interv. 1999;48:151-156.
    • (1999) Catheter Cardiovasc Interv , vol.48 , pp. 151-156
    • Elezi, S.1    Kastrati, A.2    Hadamitzky, M.3    Dirschinger, J.4    Neumann, F.J.5    Schömig, A.6
  • 9
    • 0037321509 scopus 로고    scopus 로고
    • Outcome after treatment of coronary in-stent restenosis: Results from a systematic review using meta-analysis techniques
    • Radke PW, Kaiser A, Frost C, Sigwart U. Outcome after treatment of coronary in-stent restenosis: results from a systematic review using meta-analysis techniques. Eur Heart J. 2003;24:266-273.
    • (2003) Eur Heart J , vol.24 , pp. 266-273
    • Radke, P.W.1    Kaiser, A.2    Frost, C.3    Sigwart, U.4
  • 16
    • 0037116881 scopus 로고    scopus 로고
    • Use of localised intracoronary beta radiation in treatment of stent restenosis: The INHIBIT randomised trial
    • Waksman R, Raizner AE, Yeung AC, Lansky AJ, Vandertie L. Use of localised intracoronary beta radiation in treatment of stent restenosis: the INHIBIT randomised trial. Lancet. 2002;359:551-557.
    • (2002) Lancet , vol.359 , pp. 551-557
    • Waksman, R.1    Raizner, A.E.2    Yeung, A.C.3    Lansky, A.J.4    Vandertie, L.5
  • 18
    • 0037030658 scopus 로고    scopus 로고
    • Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions: A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization
    • Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R, Group RS. Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions: a randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-1780.
    • (2002) N Engl J Med , vol.346 , pp. 1773-1780
    • Morice, M.C.1    Serruys, P.W.2    Sousa, J.E.3    Fajadet, J.4    Ban Hayashi, E.5    Perin, M.6    Colombo, A.7    Schuler, G.8    Barragan, P.9    Guagliumi, G.10    Molnar, F.11    Falotico, R.12    Group, R.S.13
  • 22
    • 0025542168 scopus 로고
    • Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease
    • Ellis S, Vandormael M, Cowley M, DiSciascio G, Deligonul U, Topol EJ, Bulle T. Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Circulation. 1990;82:1193-1202.
    • (1990) Circulation , vol.82 , pp. 1193-1202
    • Ellis, S.1    Vandormael, M.2    Cowley, M.3    Disciascio, G.4    Deligonul, U.5    Topol, E.J.6    Bulle, T.7
  • 23
    • 0023724651 scopus 로고
    • Guidelines for percutaneous transluminal coronary angioplasty: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty)
    • Guidelines for percutaneous transluminal coronary angioplasty: a report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol. 1988;12:529-545.
    • (1988) J Am Coll Cardiol , vol.12 , pp. 529-545
  • 24
    • 0028182835 scopus 로고
    • A new approach for the quantification of complex lesion morphology: The gradient field transform: Basic principles and validation results
    • van der Zwet PM, Reiber JH. A new approach for the quantification of complex lesion morphology: the gradient field transform: basic principles and validation results. J Am Coll Cardiol. 1994;24:216-224.
    • (1994) J Am Coll Cardiol , vol.24 , pp. 216-224
    • Van Der Zwet, P.M.1    Reiber, J.H.2
  • 25
    • 2942644172 scopus 로고    scopus 로고
    • Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: The randomized, double-blind, placebo-controlled, multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events after Angioplasty (VESPA) trial
    • Bestehorn HP, Neumann FJ, Büttner HJ, Betz P, Stürzenhofecker P, Hodenberg von E, Verdun A, Levai L, Monassier JP, Roskamm H. Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention: the randomized, double-blind, placebo-controlled, multicenter Verapamil Slow-Release for Prevention of Cardiovascular Events After Angioplasty (VESPA) trial. J Am Coll Cardiol. 2004;43:2160-2165.
    • (2004) J Am Coll Cardiol , vol.43 , pp. 2160-2165
    • Bestehorn, H.P.1    Neumann, F.J.2    Büttner, H.J.3    Betz, P.4    Stürzenhofecker, P.5    Von Hodenberg, E.6    Verdun, A.7    Levai, L.8    Monassier, J.P.9    Roskamm, H.10
  • 28
    • 12144289311 scopus 로고    scopus 로고
    • Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: An evaluation from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) study
    • Lemos PA, Hoye A, Goedhart D, Arampatzis CA, Saia F, van der Giessen WJ, McFadden E, Sianos G, Smits PC, Hofma SH, de Feyter PJ, van Domburg RT, Serruys PW. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) study. Circulation. 2004;109:1366-1370.
    • (2004) Circulation , vol.109 , pp. 1366-1370
    • Lemos, P.A.1    Hoye, A.2    Goedhart, D.3    Arampatzis, C.A.4    Saia, F.5    Van Der Giessen, W.J.6    McFadden, E.7    Sianos, G.8    Smits, P.C.9    Hofma, S.H.10    De Feyter, P.J.11    Van Domburg, R.T.12    Serruys, P.W.13
  • 31
    • 5344265071 scopus 로고    scopus 로고
    • Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis
    • Blackman DJ, Porto I, Shirodaria C, Channon KM, Banning AP. Usefulness of high-pressure post-dilatation to optimize deployment of drug-eluting stents for the treatment of diffuse in-stent coronary restenosis. Am J Cardiol. 2004;94:922-925.
    • (2004) Am J Cardiol , vol.94 , pp. 922-925
    • Blackman, D.J.1    Porto, I.2    Shirodaria, C.3    Channon, K.M.4    Banning, A.P.5
  • 32
    • 8544222631 scopus 로고    scopus 로고
    • Sirolimus-eluting stents for the prevention of restenosis in a worst-case scenario of diffuse and recurrent in-stent restenosis
    • Werner GS, Emig U, Krack A, Schwarz G, Figulla HR. Sirolimus-eluting stents for the prevention of restenosis in a worst-case scenario of diffuse and recurrent in-stent restenosis. Catheter Cardiovasc Interv. 2004;63:259-264.
    • (2004) Catheter Cardiovasc Interv , vol.63 , pp. 259-264
    • Werner, G.S.1    Emig, U.2    Krack, A.3    Schwarz, G.4    Figulla, H.R.5
  • 33
    • 19944425945 scopus 로고    scopus 로고
    • Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: A randomized controlled trial
    • Kastrati A, Mehilli J, von Beckerath N, Dibra A, Hausleiter J, Pache J, Schühlen H, Schmitt C, Dirschinger J, Schömig A, for the ISAR-DESIRE Study Investigators. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial. JAMA. 2005;293:165-171.
    • (2005) JAMA , vol.293 , pp. 165-171
    • Kastrati, A.1    Mehilli, J.2    Von Beckerath, N.3    Dibra, A.4    Hausleiter, J.5    Pache, J.6    Schühlen, H.7    Schmitt, C.8    Dirschinger, J.9    Schömig, A.10


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.